Skip to main content
Clinical Trials/NCT07316712
NCT07316712
Not yet recruiting
Not Applicable

Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Tendinitis

Cairo University1 site in 1 country46 target enrollmentStarted: December 30, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
46
Locations
1
Primary Endpoint
Assessment of Pain Intensity of Shoulder Joint by Numerical Rating Scale (NRS)

Overview

Brief Summary

This study aims to investigate the effect of TECAR therapy on pain, shoulder range of motion, functional disability, and handgrip strength in patients with grade II supraspinatus tendinitis.

Detailed Description

Tendinopathy occurs when pain arises in a tendon near its origin or insertion due to repetitive activities and reduced functional levels. It happens when the tendon does not properly heal. Thirty percent of tendinopathies related to musculoskeletal conditions are associated with shoulder pain, and supraspinatus tendinitis is the third most prevalent problem.

The supraspinatus tendon, part of the rotator cuff of the shoulder joint, is particularly affected. Aging is also a common factor leading to supraspinatus tendon injuries. The primary function of the supraspinatus muscle is shoulder abduction, particularly during movements that elevate the arm overhead. During these motions, the supraspinatus tendon repeatedly passes beneath the acromion process of the scapula, which can result in impingement and subsequent inflammation. An unexpected force or trauma may cause a partial or complete tendon rupture if this condition progresses.

Transfer of Energy Capacitive and Resistive (TECAR) offers a unique variety of treatments for chronic and acute pathologies, with contraindications such as pregnancy, pacemakers, and sensitivity to high temperatures. It should be noted that this new technology is a valuable tool in treating various pathologies, particularly when compared with other therapies in terms of the presence and/or absence of specific positive effects. TECAR also has distinct characteristics that are effective even when other treatments fail. This therapy balances the therapist's manual skills and the specialized energy that this technology offers, resulting in increasingly satisfactory outcomes for therapists and patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
30 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Supraspinatus Tendinitis grade II based on Neer's classification, confirmed by special tests, signs, and symptoms of grade I and II Supraspinatus Tendinitis for the past month, and taking non-steroidal anti-inflammatory drugs as suggested by the physician.
  • All patients will have a body mass index between 18.5 and 29.9 kg/m².

Exclusion Criteria

  • Other grades of Supraspinatus Tendinitis.
  • Any past shoulder surgical interventions.
  • Instability of the shoulder joint due to other reasons, Acromioclavicular Joint Arthritis.
  • Non-cooperative subjects.
  • Pregnant or lactating women.
  • Serious neuromuscular or cardiovascular diseases.
  • Systemic illness and severe COVID-19 cases will be excluded from this study.
  • Pacemakers
  • Heat Sensitivity
  • Metal Implants

Outcomes

Primary Outcomes

Assessment of Pain Intensity of Shoulder Joint by Numerical Rating Scale (NRS)

Time Frame: 3 weeks

The Numerical Rating Scale (NRS) will evaluate shoulder pain when using the NRS. Patients will be asked to rate their pain on a scale from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain possible.

Secondary Outcomes

  • Assessment of Shoulder abduction range of motion(3 weeks)
  • Assessment of Shoulder External Rotation range of motion(3 weeks)
  • Assessment of Handgrip strength by handheld dynamometer(3 weeks)
  • Assessment of Functional disability by QuickDASH Scale (Arabic Version)(3 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Gamal Ibrahem Alghamry

Principal Investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials